What is Real World Validation?

UCLPartners defines Real World Validation (RWV) of an innovation as an observed study to assess the impact and benefits to patients, staff and the health economy, in a non-controlled environment, of an innovation that has already undergone a pilot process.

All real world validation projects aim to capture:

  • Complexities of the innovation implementation process
  • Costs associated with the innovation implementation process
  • Staff and patient uptake of the innovation
  • Staff and patient satisfaction with the innovation
  • Realisation of claimed benefits of the innovation
  • Financial impact on the organisation, the NHS, and the wider health economy

UCLPartners’ real world validation process is run in partnership by UCLPartners, the innovator, and a health or social care organisation. All parties work together to deliver a real world validation report at the end of the process to answer the relevant points above.

The final real world validation report is then shared with the 15 AHSN organisations to promote the adoption and spread of the innovation in question. The report is intended to add to an innovation’s story and serve as a guide to implementation of the innovation for other organisations that may wish to adopt it.

For more information contact Chris Wood.